What’s Propelling Amarin Corporation Plc – American Depositary Share (NASDAQ:AMRN) After Higher Shorts Reported?

October 2, 2018 - By Ash

Amarin Corporation plc (NASDAQ:AMRN) Logo

Investors sentiment increased to 1.44 in Q2 2018. Its up 0.39, from 1.05 in 2018Q1. It increased, as 19 investors sold Amarin Corporation plc shares while 15 reduced holdings. 15 funds opened positions while 34 raised stakes. 101.63 million shares or 10.31% less from 113.30 million shares in 2018Q1 were reported.
Healthcare Value Limited Liability Company reported 500,000 shares or 4.38% of all its holdings. Fincl Architects invested in 10,000 shares or 0.01% of the stock. Blackrock Inc invested 0% of its portfolio in Amarin Corporation plc (NASDAQ:AMRN). Us Bank & Trust De holds 0% or 1,875 shares in its portfolio. Great Point Prtnrs Limited Liability invested in 0.45% or 1.06M shares. Proshare Advisors Limited Liability Corporation has invested 0% in Amarin Corporation plc (NASDAQ:AMRN). The New York-based Williams Jones Associates Lc has invested 0% in Amarin Corporation plc (NASDAQ:AMRN). Bank & Trust Of America De has 0% invested in Amarin Corporation plc (NASDAQ:AMRN) for 42,293 shares. Rocky Mountain Advisers Limited Company holds 0.02% or 1,600 shares. Shine Inv Advisory Incorporated stated it has 1,797 shares or 0% of all its holdings. Citigroup invested in 0% or 7,097 shares. Comerica State Bank holds 0% in Amarin Corporation plc (NASDAQ:AMRN) or 15,816 shares. Citadel Ltd Liability Corp accumulated 1.06 million shares or 0% of the stock. Lpl Llc reported 160,090 shares stake. Fmr Llc holds 5.34M shares or 0% of its portfolio.

Since June 30, 2018, it had 0 insider purchases, and 1 insider sale for $80,955 activity.

The stock of Amarin Corporation Plc – American Depositary Share (NASDAQ:AMRN) registered an increase of 45.27% in short interest. AMRN’s total short interest was 10.46M shares in October as published by FINRA. Its up 45.27% from 7.20 million shares, reported previously. With 3.51M shares average volume, it will take short sellers 3 days to cover their AMRN’s short positions. The short interest to Amarin Corporation Plc – American Depositary Share’s float is 3.91%.

The stock decreased 1.48% or $0.24 during the last trading session, reaching $16.03. About 54.82 million shares traded or 448.76% up from the average. Amarin Corporation plc (NASDAQ:AMRN) has declined 3.76% since October 2, 2017 and is downtrending. It has underperformed by 19.38% the S&P500.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company has market cap of $4.71 billion. The companyÂ’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It currently has negative earnings. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.

Amarin Corporation plc (NASDAQ:AMRN) Ratings Coverage

Among 4 analysts covering Amarin (NASDAQ:AMRN), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amarin had 4 analyst reports since May 2, 2018 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Tuesday, September 25. The firm has “Buy” rating by H.C. Wainwright given on Thursday, May 3. Cantor Fitzgerald maintained it with “Buy” rating and $1000 target in Wednesday, May 2 report. The stock of Amarin Corporation plc (NASDAQ:AMRN) earned “Buy” rating by Citigroup on Tuesday, September 25.

More notable recent Amarin Corporation plc (NASDAQ:AMRN) news were published by: Fool.com which released: “2 Healthcare Stocks That Soared in September: Can They Keep Climbing?” on October 02, 2018, also Fool.com with their article: “3 Drugmakers Not Pleased With Amarin’s Fish Oil Triumph” published on September 27, 2018, Seekingalpha.com published: “Amarin Enters The Home Stretch For Reduce-IT” on September 12, 2018. More interesting news about Amarin Corporation plc (NASDAQ:AMRN) were released by: Seekingalpha.com and their article: “Citi sees another 5x upside in Amarin” published on September 24, 2018 as well as Seekingalpha.com‘s news article titled: “Amarin up another 15%” with publication date: September 28, 2018.

Amarin Corporation plc (NASDAQ:AMRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: